期刊文献+

氧化低密度脂蛋白及其自身抗体与冠心病的相关性 被引量:1

The Study of Correlation between Coronary Heart Disease and Oxidized Low Density Lipoprotein and Autoantibody
下载PDF
导出
摘要 目的探讨氧化低密度脂蛋白(ox-LDL)及其自身抗体(ox-LDLAb)与冠心病(CHD)的相关关系,并绘制受试者工作特征曲线(ROC),评价其临床诊断意义。方法分别提取血浆和血清,用酶联免疫吸附(ELISA)方法测定血浆ox-LDL及血清ox-LDLAb浓度。结果冠心病患者ox-LDL、ox-LDLAb明显高于对照组(P<0.01),且急性心梗组(AMI)、不稳定心绞痛组(UAP)高于稳定心绞痛组(SAP)(P<0.05)。ox-LDL与ox-LDLAb)负相关。ROC曲线下面积ox-LDL为(0.805±0.039),0x-LD-LAb为(0.747±0.041),对急性冠脉综合征(ACS)有一定的鉴别力。结论血ox-LDL、ox-LDLAb水平的高低与冠心病严重程度呈正相关,可作为预测ACS和识别斑块不稳定的一项血清学指标。 Objective To study correlation of Oxidized low density lipoprotein and autoantibody with coronary heart disease. By combining the clinical condition, we tried to protract ROC curve to evaluate its clinic diagnosis value. Methods Distill serum and plasma respectively, Chemiluminescent enzymelinked immunosorbent assay was used to quantitate their plasma oxidized low-density lipoprotein and serum autoantibody of oxidized low-density lipoprotein. Results The coronary heart disease group had the higher plasma ox-LDL levels and serum ox-LDLAb than control groups, and there was obvious statistic significance (P 〈 0.01 ). The AMI and UAP groups had the higher plasma ox-LDL and serum ox-LDLAb levels than SAP groups(P 〈 0.05 ), there was no significant difference among AMI and UAP groups, plasma ox-LDL was negative correlated to serum ox-LDLAb. The areas under ROC curve of plasma ox-LDL and serum ox-LDLAb respectively was 0.805 ± 0. 039 and 0. 747 ± 0. 041. This indicated that they have some certain diagnostic value. Conclusion plasma ox-LDL and serum ox-LDLAb levels were significant correlated to the serious degree of coronary heart disease. They can identify the unstable plaque.
出处 《中国分子心脏病学杂志》 CAS 2005年第1期410-414,F0003,共6页 Molecular Cardiology of China
基金 教育部振兴行动计划资助项目
关键词 冠心病 氧化低密度脂蛋白 抗氧化低密度脂蛋白自身抗体 斑块稳定性 Coronary Heart Diseases Plaque stability Oxidized Low-density lipoprotein autoantibedy of Oxidized Low-density lipoprotein.
  • 相关文献

参考文献15

  • 1[1]Hansson GK. Immune mechani sms in atherosclerosis. Arterioscler Thromb Vasc Biol,2001, 21:1876-1890.
  • 2[2]Landmesser U, Harrison DG. Oxidant stress as a marker for cardiovascular events: Ox marks the spot. Circulation,2001,104:2638-2640.
  • 3[3]Tsimikas S, Witztum JL. The oxidative modification hypothesis of atherosclerosis. In: Keaney JF, editor. Oxidative stress and vascular disease. Boston, MA: Kluwer Academic. 2000,49-74.
  • 4[4]Navab M, Berliner JA, Watson AD, et al. The Yin and Yang of oxidation in the development of the fatty streak. Atheroscler Thromb Vasc Biol, 1996,16:83 1-842.
  • 5[5]Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronery syndromes. Circulation,2001,103:1955-1960.
  • 6[6]Tsimikas S, Witztum JL. Measuring circulating oxidized low density lipoprotein to evaluate coronary risk. Circulation,2001,103: 1930-1932.
  • 7[7]Tanaga K, Bujo H,Inoue M,et al. Increased circulating Malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol ,2002,22:662-666.
  • 8[8]Sotirios Tsimikas MD, Claes Bergmark MD, Reinaldo W, et al. Temporal increases in Plasma markers of oxidized low density lipoprotein strongly reflect the presence of acute coronary syndrome. J Am Coll Cardio, 2003,3: 360-370.
  • 9[9]Inoue T, Uchida T, Kamishirado H, et al. Clinical significance of antibody against oxidized LDL in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol,2001,37 :775-779.
  • 10[10]Arja TE, Outi N, Seppo L, et al. Autoantibodies against oxidized low density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol,2000 ,20 :204-209.

同被引文献8

  • 1朱桂勤,李建科.茶多酚的功能研究进展[J].食品研究与开发,2005,26(1):33-35. 被引量:70
  • 2王拥军,温玫,庞式琪.氧化型低密度脂蛋白的制备[J].首都医学院学报,1996,17(1):32-35. 被引量:8
  • 3BOUIS D,HOSPERS G A,MEIJER C,et al.Endothelium in vitro:a review of human vascular endothelial cell lines for blood vessel-related research[J].Angiogenesis,2001,4(2):91-102.
  • 4MERTENS A,HOLVOET P.Oxidized LDL and HDL:antagonists inatherothrombosis[J].FASEB,2001,15:2073-2084.
  • 5KUO C C,HSIEH H P,PAN W Y,et al.BPR0L075,a novel synthetic indole compound with antimitotic activity in human cancer cells,exerts effective antitumoral activity in vivo[J].Cancer Res,2004,64(13):4621-4628.
  • 6YANAZAKI Y,TSURUGA M,ZHOU D,et al.Cytoskeletal disruption accelerates caspase-3 activa-tion and alters the intracellular membrane reorganization in DNA damage-induced apoptosis.Exp Cell Res,2000,259(1):64-78.
  • 7CHENG Y L,LEE S C,LIN S Z,et al.Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo[J].Cancer Lett,2005,222 (2):183-193.
  • 8于荣,袁明,王学臣.微管骨架的动态特性及其调控[J].植物学通报,1998,15(6):19-29. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部